How to differentiate ADHD symptoms from substance effects
Recognising ADHD when substance use is involved can be difficult, even for experienced clinicians. According to NICE and NHS England, alcohol, stimulants, cannabis, and opioids can temporarily mimic or hide ADHD traits leading to frequent misdiagnosis or delayed treatment.
When symptoms overlap
ADHD typically causes lifelong patterns of inattention, impulsivity, and emotional dysregulation that begin in childhood and persist across different settings. By contrast, substance use and withdrawal can produce short-term changes that look similar but have different origins. For example, intoxication may lead to disinhibition, poor concentration, and restlessness, while withdrawal can bring lethargy, irritability, or anxiety that obscure the true picture (RCPsych, 2025). Clinicians are therefore advised to look for chronicity and early onset; ADHD symptoms generally appear long before any substance use begins (NHS RDaSH ADHD Formulary Guidance).
Timing and assessment
The NICE NG87 guideline recommends assessing ADHD only once intoxication or withdrawal effects have settled, ideally after a period of stability or abstinence. The NHS England ADHD Taskforce (2025) and the Royal College of Psychiatrists also advise that early screening can occur during active substance use, but full diagnosis should be delayed until symptoms can be observed without substance influence. When immediate assessment is essential, NICE stresses the importance of collateral history from family, teachers, or carers to confirm lifelong symptom patterns and functional impairment.
Best practice and clinical guidance
NICE and RCPsych guidance recommend using structured interviews, validated ADHD checklists, and multidisciplinary assessment, never relying solely on self-report during intoxication or withdrawal. New NHS service models advocate for closer integration between addiction and neurodevelopmental teams to ensure accurate diagnosis and safe ongoing care (NHS England Service Advice, 2025).
Why it matters
People living with both ADHD and substance use disorders face longer delays in diagnosis and poorer recovery outcomes if symptoms are not properly distinguished. According to RCPsych, missed or inaccurate diagnosis can worsen both conditions. Private and NHS services such as ADHD Certify can support comprehensive assessments and medication reviews, complementing public care pathways.
Takeaway
ADHD and substance use often overlap, but understanding timing, chronicity, and history helps clinicians tell them apart. By following NICE and NHS guidance, and combining addiction and neurodevelopmental expertise, healthcare professionals can provide safer, more effective assessments and better outcomes for people affected by both.

